Growth hormone therapy for Prader-Willie and down syndromes: A post-modern medical dilemma

Growth Hormone and IGF Research

Volumn 10, Issue SUPPL. B, 2000, Pages

  Lantos, J D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Ethics; Growth hormone; Post modernism

Indexed keywords

GROWTH HORMONE;

CLINICAL PROTOCOL; DOWN SYNDROME; DRUG EFFICACY; GROWTH RATE; GROWTH RETARDATION; HEIGHT; HORMONAL THERAPY; HUMAN; MEDICAL ETHICS; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0033874318     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(00)80017-9     Document Type: Note

References (2)

1. Medicine, postmodernism, and the end of certainty
2. Ethical issues in emerging new treatments such as growth hormone therapy for children with Down syndrome and Prader-Willi syndrome